Biomavens
About

Built at the intersection of healthcare buyers and the companies that serve them.

Biomavens is led by a senior commercial operator — three decades inside healthcare & life sciences, and alongside the HLS-facing companies trying to win there: health tech, health IT, AI and data vendors, platforms, services firms, agencies, and commercialization partners.

Perspective

Why Biomavens sees commercialization differently.

Biomavens was built from a pattern repeated across the companies that sell into healthcare & life sciences: real capability, credible platforms, strong teams, meaningful revenue — and growth that still struggles to become repeatable with HLS buyers.

The missing layer is rarely another feature or another claim. It's the connection between what the company can do and what an HLS executive is actually trying to decide — translated into a clear offer, a credible story, and a sales motion the team can run.

Most advisors live in strategy or in execution. Biomavens was built at the intersection of the two — and at the seam between healthcare buyers and the companies serving them.

Biomavens helps healthcare-facing companies move from capability-led selling to decision-led growth.

Mike Strassberg, Founder and Principal of Biomavens
Founder

Mike Strassberg

Founder & Principal

A commercial operator with more than three decades inside healthcare & life sciences — and alongside the HLS-facing companies trying to grow within it.

Built and scaled commercial organizations from revenue plateau to multi-year growth, stood up GTM motions for early-stage healthcare AI, and advised executive teams through repositioning, expansion, and transformation.

Engagements are led personally.

LinkedIn profile →
Ecosystem Experience

Operating depth across HLS — and alongside the companies selling into it.

Repeated exposure across
Health TechHealth ITAI / DataPharma & Life SciencesPayerProviderAgencyConsultingCommercialization
Same patterns, every time
  • —Capability → Buyer
  • —Vendor → Advisor
  • —Founder → System
  • —Plateau → Growth
Three decades of seeing the same growth patterns repeat across HLS-facing companies.
HLS-facing companies
The center of the work — helping health tech, health IT, AI and data vendors, platforms, agencies, consultancies, and services firms become more valuable to the HLS buyers they sell into.
Payer
Operating inside the coverage and formulary decisions that quietly shape what enterprise healthcare actually adopts.
Provider
Working inside health systems and enterprise buyers — where clinical, financial, and IT priorities collide, and where a great pilot still has to survive procurement.
Pharma & Life Sciences
Brand, access, evidence, and field execution — the operating reality every healthcare-facing vendor has to design around.
Healthcare AI & Digital Health
Translating model capability into enterprise adoption — where the buying committee is bigger than the demo audience, and trust has to be earned in operating terms.
Strategy + Execution

Operationalizing commercialization — not just recommending it.

01
Strategy alone does not commercialize.

Decks land. Markets don't move because of decks. Biomavens treats commercialization as an operating problem, not a strategic one.

02
Execution alone does not scale.

Activity without architecture creates motion, not outcomes. Biomavens connects strategy, decisions, and execution into a single operating cadence.

03
The intersection is where value is created.

Commercialization works when people, process, platforms, and decisions align — the load-bearing foundation underneath every Biomavens engagement.

If commercialization has to land — not just be announced — let's talk.

Start a strategic conversation